Pharmsynthez (MOEX:LIFE)
Russia flag Russia · Delayed Price · Currency is RUB
4.505
+0.415 (10.15%)
At close: Jul 8, 2022

Pharmsynthez Balance Sheet

Millions RUB. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2.191.524.989.1715.310.41
Short-Term Investments
2.562.54----
Cash & Short-Term Investments
4.764.064.989.1715.310.41
Cash Growth
143.60%-18.50%-45.74%-40.03%46.89%-84.44%
Accounts Receivable
193.9928.8796.0172.0369.0666.02
Other Receivables
-145.12169.070.88.03164.1
Receivables
193.99174265.0877.5579.21288.79
Inventory
72.9462.6263.5641.9536.1969.56
Prepaid Expenses
---69.3875.5496.32
Other Current Assets
2.621.636.160.040.040.04
Total Current Assets
274.29262.27369.79198.1206.27465.13
Property, Plant & Equipment
422.63430.94468.54344.58326.7352.12
Long-Term Investments
783.32781.5793.1433.5125.14487.73
Other Intangible Assets
211.74211.86216.21331.9337.23349.83
Long-Term Deferred Tax Assets
1,0441,0411,086366.61365.25329.17
Other Long-Term Assets
---63.2363.2368.2
Total Assets
2,7362,7272,9341,3381,4252,052

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Accounts Payable
546.65530.94442.52178.66141.29177.76
Accrued Expenses
-16.8115.63105.61104.1883.88
Short-Term Debt
386.19361.85335591.72579.81573.52
Current Portion of Long-Term Debt
---103.2241.5535.85
Current Portion of Leases
1.030.939.878.69-0.95
Current Income Taxes Payable
---29.2315.5512.31
Other Current Liabilities
24.583.1543.75157.93110.95140.58
Total Current Liabilities
958.45913.67846.771,175993.331,025
Long-Term Debt
---16.5586.8513.2
Long-Term Leases
0.610.9320.1525.22--
Total Liabilities
959.06914.6866.921,2171,0801,038

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Common Stock
2,2022,2022,2021,5051,5051,505
Additional Paid-In Capital
4,8534,8534,8533,5313,5313,531
Retained Earnings
-5,278-5,242-4,988-4,445-4,238-3,540
Comprehensive Income & Other
000-469.45-452.76-481.47
Total Common Equity
1,7761,8132,067121.1345.281,014
Shareholders' Equity
1,7761,8132,067121.1345.281,014
Total Liabilities & Equity
2,7362,7272,9341,3381,4252,052

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Total Debt
387.83363.71365.02745.4708.21623.52
Net Cash (Debt)
-383.08-359.65-360.04-736.23-692.91-613.1
Net Cash Growth
------
Net Cash Per Share
-0.86-0.82-0.82-2.45-2.30-2.04
Filing Date Shares Outstanding
440.39440.39456.83301.01301.01301.01
Total Common Shares Outstanding
440.39440.39456.83301.01301.01301.01
Working Capital
-684.16-651.4-476.98-976.95-787.05-559.73
Book Value Per Share
4.034.124.520.401.153.37
Tangible Book Value
1,5651,6011,850-210.88.05664.29
Tangible Book Value Per Share
3.553.634.05-0.700.032.21
Land
-181.5150.73161.11159.14155.22
Buildings
-160.7182.39---
Machinery
-323.29320.59515.92523.17541
Construction In Progress
---143.66143.66143.66